The hybrid CD8+ DMβ-T cells efficiently controlled target tumors and prolonged survival (figure 4B,C) while V49I-T cells and wtc51m-T cells did not delay tumor outgrowth and treated mice had similar limited survival (figure 4B). This evidence concerns the gene CD8A and neoplasm.